Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomised, Double-blind, Placebo-controlled, Phase IIa Pilot Study to Evaluate the Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) in Patients With Uncomplicated, Gram-positive, Skin
Brief Summary:
The purpose of this study is to evaluate the safety and tolerability of Lytixar™ applied topically to uncomplicated skin infections.
Three dose levels of Lytixar™ (1%, 2% and 5%) versus placebo will be tested.